6.54
+0.05(+0.77%)
Currency In USD
| Previous Close | 6.49 |
| Open | 6.2 |
| Day High | 6.73 |
| Day Low | 5.62 |
| 52-Week High | 16.74 |
| 52-Week Low | 4.25 |
| Volume | 2.17M |
| Average Volume | 1.44M |
| Market Cap | 1.01B |
| PE | -9.34 |
| EPS | -0.7 |
| Moving Average 50 Days | 8.22 |
| Moving Average 200 Days | 9.93 |
| Change | 0.05 |
If you invested $1000 in Wave Life Sciences Ltd. (WVE) since IPO date, it would be worth $408.75 as of May 09, 2025 at a share price of $6.54. Whereas If you bought $1000 worth of Wave Life Sciences Ltd. (WVE) shares 5 years ago, it would be worth $646.88 as of May 09, 2025 at a share price of $6.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025
GlobeNewswire Inc.
May 01, 2025 12:30 PM GMT
CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and confe
Wave Life Sciences Announces Positive Data from FORWARD-53 Clinical Trial in DMD Including Significant Functional Benefit and Reversal of Muscle Damage after 48 Weeks of Dosing with WVE-N531
GlobeNewswire Inc.
Mar 26, 2025 11:30 AM GMT
Statistically significant and clinically meaningful improvement of 3.8 seconds in Time-to-Rise vs. natural history with largest effect observed relative to any approved dystrophin restoration therapy at 48 weeks; additional functional benefits observ
Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025
GlobeNewswire Inc.
Feb 25, 2025 1:30 PM GMT
CAMBRIDGE, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conf